Skip to main content
. 2021 Jan;10(1):304–313. doi: 10.21037/tlcr-20-380

Figure 4.

Figure 4

Metabolites significantly altered in patients with NSCLC before treatment start and progressing after the first follow up scan. Fold-changes express the ratio of a certain metabolite in the subcohort of primary refractory NSCLC patients at timepoint of cancer progression divided by baseline levels. NSCLC, non-small cell lung cancer.